nLife Therapeutics

nLife Therapeutics develops cell-specific oligonucleotides for genetic medicines, focusing on novel genetic therapies

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical development

Model

01Company Overview

nLife Therapeutics develops cell-specific oligonucleotides for genetic medicines, focusing on novel genetic therapies.

02Backed By1 investor

03Similar Companies

OH

Oak Hill Bio

Biotech & Life Sciences

→

CM

AB

ST

CB

04Startup DNA

8

signals

Sectors
Business Model
Technology